Diretrizes da World Federation of Societies of Biological Psychiatry (WFSBP) para tratamento biológico de transtornos depressivos unipolares, 1a parte: Tratamento agudo e de continuação do transtorno depressivo maior

Translated title of the contribution: World Federation of Societies of Biological Psychiatry (WFSBP) guidelines for biological treatment of unipolar depressive disorders, part 1: Acute and continuation treatment of major depressive disorder

Michael Bauer, Peter C. Whybrow, Jules Angst, Marcio Versiani, Hans Jürgen Möller, Hervé Allain, Ian Anderson, José L. Ayuso-Gutierrez, David Baldwin, Per Bech, Otto Benkert, Michael Berk, Istvan Bitter, Marc L. Bourgeois, Graham Burrows, Giovanni Cassano, Marcelo Cetkovich-Bakmans, John C. Cookson, Delcir Da Costa, Mihai D. GherogheGerardo Heinze, Teruhiko Higuchi, Robert M. Hirschfeld, Cyril Höschl, Edith Holsboer-Trachsler, Siegfried Kasper, Cornelius Katona, Martin B. Keller, Parmanand Kulhara, David J. Kupfer, Yves Lecrubier, Brian Leonard, Rasmus W. Licht, Odd Lingjaerde, Henrik Lublin, Julien Mendlewicz, Philip Mitchell, Eugene S. Paykel, Stanislaw Puzynski, A. John Rush, Janusz K. Rybakowski, Isaac Schweitzer, Jürgen Unützer, Per Verstergaard, Eduard Vieta, Kazuo Yamada, Jens Wiltfang

Research output: Contribution to journalReview article

4 Citations (Scopus)

Abstract

These practice guidelines for the biological treatment of unipolar depressive disorders were developed by an international Task Force of the World Federation of Societies of Biological Psychiatry (WFSBP). The goal for developing these guidelines was to systematically review all available evidence pertaining to the treatment of unipolar depressive disorders, and to produce a series of practice recommendations that are clinically and scientifically meaningful based on the available evidence. These guidelines are intended for use by all physicians seeing and treating patients with these conditions. The data used for developing these guidelines have been extracted primarily from various national treatment guidelines and panels for depressive disorders, as well as from meta-analyses and reviews on the efficacy of antidepressant medications and other biological treatment interventions identified by a search of the MEDLINE database and Cochrane Library. The identified literature was evaluated with respect to the strength of evidence for its efficacy and was then categorized into four levels of evidence (A-D). This first part of the guidelines covers disease definition, classification, epidemiology and course of unipolar depressive disorders, as well as the management of the acute and continuation-phase treatment. These guidelines are primarily concerned with the biological treatment (including antidepressants, other psychopharmacological and hormonal medications, electroconvulsive therapy, light therapy, adjunctive and novel therapeutic strategies) of young adults and also, albeit to a lesser extent, children, adolescents and older adults.

Original languagePortuguese
Pages (from-to)17-57
Number of pages41
JournalRevista de Psiquiatria Clinica
Volume36
Issue numberSUPPL. 2
DOIs
Publication statusPublished - Dec 1 2009

    Fingerprint

Keywords

  • Acute treatment
  • Antidepressants
  • Biological treatment
  • Continuation treatment
  • Evidence-based guidelines
  • Major depressive disorder
  • Pharmacotherapy

ASJC Scopus subject areas

  • Psychiatry and Mental health

Cite this

Bauer, M., Whybrow, P. C., Angst, J., Versiani, M., Möller, H. J., Allain, H., Anderson, I., Ayuso-Gutierrez, J. L., Baldwin, D., Bech, P., Benkert, O., Berk, M., Bitter, I., Bourgeois, M. L., Burrows, G., Cassano, G., Cetkovich-Bakmans, M., Cookson, J. C., Costa, D. D., ... Wiltfang, J. (2009). Diretrizes da World Federation of Societies of Biological Psychiatry (WFSBP) para tratamento biológico de transtornos depressivos unipolares, 1a parte: Tratamento agudo e de continuação do transtorno depressivo maior. Revista de Psiquiatria Clinica, 36(SUPPL. 2), 17-57. https://doi.org/10.1590/S0101-60832009000800001